We are live on ! Find out more
PVCT

PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT

Delisted

PVCT was delisted on the 13th of October, 2016.

Back to rankings

4 hedge funds and large institutions have $10K invested in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 4 → 4 (0)

23% less capital invested

Capital invested by funds: $13K → $10K (-$3K)

Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

PVCT Hedge Fund Activity: Q1 2018 in Review

4 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) for Q1 2018, worth a combined $10K — down 23% from $13K a quarter earlier.

Fund positioning in PVCT was balanced in Q1 2018: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 4 institutional investors held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) as of Q1 2018, unchanged from Q4 2017.
  • Funds reported $10K of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) stock for Q1 2018, down 23% quarter-over-quarter.
  • 0 funds opened new PROVECTUS BIOPHARMACEUTICALS, INC. (DE) positions in Q1 2018 and 0 closed out.

Based on aggregated 13F filings for Q1 2018.